Expression profile of mRNAs and miRNAs related to mitogen-activated kinases in HaCaT cell culture treated with lipopolysaccharide a and adalimumab
M Wójcik, A Plata-Babula, A Głowaczewska, T Sirek… - Cell Cycle, 2024 - Taylor & Francis
Studies indicate that mitogen-activated protein kinases (MAPKs) exhibit activation and
overexpression within psoriatic lesions. This study aimed to investigate alterations in the …
overexpression within psoriatic lesions. This study aimed to investigate alterations in the …
Could serum HMGB1 levels be a predictor associated with psoriatic arthritis?
Background/aim: Psoriasis is a chronic autoimmune disease that predominantly affects the
skin and musculoskeletal system. We hypothesized that HMGB1, an inflammatory nuclear …
skin and musculoskeletal system. We hypothesized that HMGB1, an inflammatory nuclear …
Daturataturin A Ameliorates Psoriasis by Regulating PPAR Pathway
Z Wei, H Zhong, S Yuan, C Chen - Biochemical Genetics, 2024 - Springer
Psoriasis is a kind of severe immune-mediated systemic skin disorder, becoming a
worldwide public health concern. Daturataturin A (DTA), a withanolide compound, exerts …
worldwide public health concern. Daturataturin A (DTA), a withanolide compound, exerts …
[HTML][HTML] Excimer Laser System: The Revolutionary Way to Treat Psoriasis
A Alyoussef - Cureus, 2023 - ncbi.nlm.nih.gov
Psoriasis is a chronic, autoinflammatory skin disease that affects approximately 100 million
people worldwide. It is a systemic disease characterized by scaly, red patches on the skin …
people worldwide. It is a systemic disease characterized by scaly, red patches on the skin …
[PDF][PDF] A Brief Overview of miRNAs Orchestrating the Pathogenesis of Psoriasis
Psoriasis is a complex chronic inflammatory skin disorder triggered by environmental factors
in genetically susceptible individuals. Genomic and immunological studies have guided the …
in genetically susceptible individuals. Genomic and immunological studies have guided the …